Describing pain can improve patient provider communication. Discover tips on how to describe pain in AiArthritis diseases

Heart health doesn’t always get the attention it deserves in AiArthritis disease care. Learn why this needs to change.

Learn about the latest information about brain fog and sleep issues in AiArthritis diseases

Stay up to date on the latest European Alliance of Associations for Rheumatology (EULAR) insights on enthesitis.

Living with unexplained symptoms can be isolating and overwhelming. Discover coping strategies, self-care tips, and emotional support for navigating the uncertainty of autoimmune and autoinflammatory disease diagnosis.

Learn about the latest research in lupus and lupus nephritis.

Read about the latest psoriatic arthritis research presented at EULAR 2025

Discover practical strategies for incorporating nutrition, exercise, and stress reduction techniques into daily life to support long-term well-being

Discover the latest news about Still's Disease in this debrief from EULAR 2025

Learn why the transition from pediatric to adult rheumatology care is about more than changing doctors. Discover how building skills, confidence, and support empowers young people to manage lifelong rheumatic disease during a critical stage of life.

Tracking your AiArthritis disease symptoms can improve the patient journey. Discover why and tips on how to track your symptoms.

Celebrating National Caregiver Day and their support for people living with AiArthritis diseases.

Explore the key points to a EULAR 2025 debate on cannabis for AiArthritis Diseases.

Pain is one of the most common and most misunderstood parts of living with autoimmune and autoinflammatory arthritis. Learn more about pain and what works beyond medications.

Managing multiple specialists and treatment plans for autoimmune and autoinflammatory arthritis requires organization, proactive communication, and advocacy. Discover tips on how to do this.

Learn about the latest updates in axial spondyloarthritis research

Cannabis use among people living with autoimmune and autoinflammatory arthritis (AiArthritis) has quietly shifted from a fringe conversation to a mainstream reality. Patients are using it for pain, sleep, nausea, anxiety, mood, and quality of life—often long before their doctors feel comfortable discussing it.

AiArthritis commissioned Milliman Insight to analyze newly available hospital reimbursement data for autoimmune drugs. These findings raise important questions about transparency, accountability, and how the 340B program is impacting patients. Discover more.

A recap of the “Go With Us!” Patient-Led Debrief highlighting key takeaways from ACR and EULAR 2025, including early diagnosis, precision medicine, advocacy, mental health, and integrative approaches to AiArthritis disease care.